From the ∗Department of Nuclear Medicine, Division of Diagnostic Imaging

†Department of Interventional Radiology, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX.

Received for publication May 2, 2023; revision accepted August 8, 2023.

Conflicts of interest and sources of funding: none declared.

Correspondence to: Guofan Xu, MD, PhD, Department of Nuclear Medicine, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Unit Number 1483, 1400 Pressler St, Houston, TX 77030. E-mail: [email protected].